Provided by Tiger Trade Technology Pte. Ltd.

Core Assets of Southward Funds

977.934
+13.8461.44%
Number of Gainers:44
Number of Losers:19
Number of Flat:4
PE:- -
High:981.916
Open:964.067
Low:964.067
Close:964.088
Volume:918.32M
Turnover:24.94B
Market Cap:13.26T
Float Cap:12.29T

Loading ...

Southbound Trading Update: Net Buy of HKD 15 Million, Increased AIA (01299) Stake by Over HKD 800 Million, Sold Off Alibaba (09988) Over HKD 500 Million

Stock News
·
Sep 29

Why Did Shanxi's Richest Woman Take 1 Billion Yuan Less from China's Richest Man?

Deep News
·
Sep 29

Tencent Repurchases 232,000 Shares for HK$100.6 Million on September 29

Stock News
·
Sep 29

MENGNIU DAIRY (02319) Spends HK$71,200 to Repurchase 4,000 Shares on September 29

Stock News
·
Sep 29

ES SERVICES (01995) Spends HK$347,100 to Repurchase 200,000 Shares on September 29

Stock News
·
Sep 29

Goldman Sachs cuts Bud APAC (01876) target price to HK$6.9 as continued weakness in China market weighs on EBITDA

Stock News
·
Sep 29

Citi: Sino Biopharmaceutical and STADA Form Biosimilar Strategic Partnership, "Buy" Rating Maintained

Stock News
·
Sep 29

ANTA Sports Ranks No. 1 in China Textiles, Apparel and Luxury Goods in S&P Global 2026 Sustainability Assessment

Reuters
·
Sep 29

Galaxy Entertainment Group Stock Falls 0.8% in Hong Kong

Dow Jones
·
Sep 29

Xinyi Solar Holdings Stock Slides 1.0% in Hong Kong

Dow Jones
·
Sep 29

Tencent Holdings Stock Falls 1.8% in Hong Kong

Dow Jones
·
Sep 29

Meituan Stock Sheds 2.0% in Hong Kong

Dow Jones
·
Sep 29

China Feihe - Declare a Special Dividend of Hk$0.2905 Per Share

THOMSON REUTERS
·
Sep 29

Xiaomi Stock Slides 2.6% in Hong Kong

Dow Jones
·
Sep 29

Budweiser Brewing Co. APAC Stock Falls 4.8% in Hong Kong

Dow Jones
·
Sep 29

CLSA: China Semiconductor Demand Momentum Remains Solid, Foundries Continue Expanding Capacity

Stock News
·
Sep 29

Sino Biopharm Unit CTTQ Presents Phase 3 APEX-Breast01 Data for Tqb2102 in HER2-Low Breast Cancer at ESMO 2026

Reuters
·
Sep 29

Innovent Says Trispecific Antibody Ibi3003 Posts 84.6% ORR at Phase 1 RP2D in Relapsed/refractory Multiple Myeloma

Reuters
·
Sep 29

2026 Ims Oral Presentation: Innovent Announces Updated Phase 1 Clinical Data of Trispecific Antibody Ibi3003 (Gprc5d/Bcma/Cd3) in Patients with Relapsed or Refractory Multiple Myeloma

THOMSON REUTERS
·
Sep 29

Jefferies Adjusts Budweiser Brewing Company APAC's Price Target to HK$7.50 From HK$8.40, Keeps at Buy

MT Newswires Live
·
Sep 29